Precision Optics Corporation, Inc.

POCI ·Healthcare, Medical Devices, United States
Analysis › Moat Score

Moat Score — Precision Optics Corporation, Inc.

Total Moat Score 9 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 2 / 5 POCI holds decades of proprietary optical and opto-mechanical design know-how and FDA-cleared product designs (e.g., the Unity Imaging Platform), but its patent estate is thin relative to larger medical-device and optics players, limiting durability of this edge.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 1 / 5 As a sub-scale manufacturer (~$19M revenue), POCI has no cost advantage versus larger OEMs or offshore optics manufacturers; FY2025 gross margin collapsed to 17.8% from 30.3% precisely because fixed-price contracts left it exposed to rising input costs.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 1 / 5 Many contracts are fixed-price and quoted well ahead of delivery, so POCI has limited ability to pass through cost inflation on precision glass and CMOS sensors, as the FY2025 margin compression demonstrates.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 0 / 5 There is no network effect in contract optical design and manufacturing; value does not increase with the number of users or customers on the platform.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 3 / 5 Once POCI's optics are designed into a customer's FDA-cleared device or qualified defense program, requalifying an alternate supplier is slow and costly, giving POCI real (though customer-concentrated) lock-in on existing programs.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 2 / 5 The micro-optics and low-volume single-use endoscope niches are often too small and specialized for large OEMs to service economically in-house, giving POCI room to operate without large-scale competitors crowding in, though this also caps its own growth ceiling.